Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

124.66
-2.0400-1.61%
Post-market: 126.471.81+1.45%19:32 EDT
Volume:275.91K
Turnover:33.97M
Market Cap:1.83B
PE:-14.04
High:129.88
Open:124.98
Low:120.62
Close:126.70
52wk High:155.29
52wk Low:26.19
Shares:14.67M
Float Shares:8.64M
Volume Ratio:0.79
T/O Rate:3.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8768
EPS(LYR):-9.0434
ROE:-1773.60%
ROA:-43.61%
PB:-34.52
PE(LYR):-13.78

Loading ...

Jun 16, 2022

Major Issues Report

8-K - Current report
May 25, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Major Issues Report

8-K - Current report
Apr 05, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 03, 2022

Major Issues Report

8-K - Current report
Mar 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Major Issues Report

8-K - Current report